Effect of Losartan on Chronic Obstructive Pulmonary Disease (COPD)
| Status: | Completed |
|---|---|
| Conditions: | Bronchitis, Chronic Obstructive Pulmonary Disease, Pulmonary |
| Therapuetic Areas: | Pulmonary / Respiratory Diseases |
| Healthy: | No |
| Age Range: | 40 - Any |
| Updated: | 3/30/2013 |
| Start Date: | May 2008 |
| End Date: | September 2012 |
| Contact: | Marie Daniel |
| Email: | mdaniel@jhmi.edu |
| Phone: | 410 550-0800 |
Effect of Losartan on Airway Parameters in COPD
Losartan, an angiotensin receptor blocker, has been effective in preventing the development
of emphysema and lung inflammation in animal models of COPD. Moreover, there is
epidemiologic evidence that suggests that this drug may be effective in reducing COPD
morbidity and mortality.
This study will provide treatment with either losartan or placebo for a period of 12 months
to determine whether there is progression of COPD as measured by high-resolution CT scans,
lung function, or blood tests for inflammation.
Inclusion Criteria:
- Evidence of COPD by pulmonary function testing
Exclusion Criteria:
- Clinical indication for angiotensin receptor blockers or ACE inhibitors
- Significant kidney disease or heart disease
- History of intolerance to losartan or similar drugs
We found this trial at
1
site
Johns Hopkins Hospital Patients are the focus of everything we do at The Johns Hopkins...
Click here to add this to my saved trials
